The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vaginosis
|ClinicalTrials.gov Identifier: NCT01258556|
Recruitment Status : Completed
First Posted : December 13, 2010
Last Update Posted : December 13, 2010
|Condition or disease||Intervention/treatment||Phase|
|Bacterial Vaginosis||Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti Dietary Supplement: Yogurt not supplemented with a probiotic strain.||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Study Start Date :||June 2010|
|Primary Completion Date :||July 2010|
|Experimental: Probiotic yogurt||
Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti
200 ml of L. rhamnosus fiti at 10*9 cfu/ml daily for 30 days.
|Placebo Comparator: Placebo yogurt.||
Dietary Supplement: Yogurt not supplemented with a probiotic strain.
200 ml yoghurt without L. rhamnosus fiti daily for 30 days.
- Vaginal microbiota of HIV patients. [ Time Frame: 30 days ]
- Bacterial vaginosis. [ Time Frame: 30 days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01258556
|Sekou-Toure Regional Hospital|
|Principal Investigator:||Nicodemus Butamanya, MD||Sekou-Toure Regional Hospital|